Mcgraw-Hill Turns to Impelsys for Electronic Content Delivery
Professional Division of McGraw-Hill re-launches leading genetic information source with simplified online access using Impelsys technologies.
New York, NY, February 24, 2008 --(PR.com)-- Impelsys, Inc., a leader in providing electronic content delivery solutions to the global publishing market, was the powering force behind the re-launch of McGraw-Hill Professional’s Scriver’s Online Metabolic and Molecular Bases of Inherited Diseases (OMMBID) at http://www.ommbid.com. Scriver’s OMMBID provides online access to leading genetic information from renowned international experts. Geneticists, scientists, physicians, educators and students will now have access to the world renowned reference for genetics and inherited diseases.
The re-launch of OMMBID utilizes Impelsys’ iPlatform™ content delivery solution, a cost effective powerful portal solution for publishers. Impelsys hosts and maintains the application. iPlatform creates a media rich web portal around OMMBID content creating the next generation of online books. The company’s iPlatform allows users to have personalized features enabling them to create an image library, bookmark specific chapters, add personal notes and comment on chapters. In addition, users can conduct a Quick or Advanced semantically tagged search when targeting specific content, limiting results to images and tables.
According to Sameer Shariff, Impelsys founder and CEO, one of the highlights of Scriver’s Online is a new iPlatform feature that provides an author workflow system that allows monthly chapter updates by the editorial staff through an XML to Microsoft Word editor. This feature allows editors to quickly and efficiently edit online content whenever necessary. iPlatform’s powerful eCommerce components allows institutional and individual subscribers access to the entire site as well as providing users the option of purchasing individual chapters.
“We are very honored to be associated in supporting the OMMBID platform,” said Impelsys CEO Sameer Shariff. “As the leading source for genetics information, we look forward to implementing the latest web technologies in order to provide OMMBID users the best experience in getting to their content.”
About Impelsys
Impelsys, a leader in providing electronic content delivery solutions to the global publishing market operates two groups —Impelsys Products and Impelsys Services — that help clients compete, evolve and grow in an increasingly complex marketplace. Impelsys products include iPlatform™, VirtualPages™ and SmartCD™. These products help publishers deliver content online quickly and cost effectively. Impelsys services through its offshore delivery center, helps its customers with software development, maintenance, multimedia development and eLearning services.
Impelsys’ passion for client success has helped it build long term partnerships with its customers becoming critical in the client’s electronic delivery strategy. Leading clients, including McGraw-Hill, Reed Elsevier, Wolters Kluwer, Thomson, Springer, Benchmark Education, Marshall Cavendish and Houghton Mifflin rely on the company’s unique approach to drive growth and market momentum. Headquartered in New York City, Impelsys operates across North America, Europe and India. For more information, please visit www.impelsys.com.
###
The re-launch of OMMBID utilizes Impelsys’ iPlatform™ content delivery solution, a cost effective powerful portal solution for publishers. Impelsys hosts and maintains the application. iPlatform creates a media rich web portal around OMMBID content creating the next generation of online books. The company’s iPlatform allows users to have personalized features enabling them to create an image library, bookmark specific chapters, add personal notes and comment on chapters. In addition, users can conduct a Quick or Advanced semantically tagged search when targeting specific content, limiting results to images and tables.
According to Sameer Shariff, Impelsys founder and CEO, one of the highlights of Scriver’s Online is a new iPlatform feature that provides an author workflow system that allows monthly chapter updates by the editorial staff through an XML to Microsoft Word editor. This feature allows editors to quickly and efficiently edit online content whenever necessary. iPlatform’s powerful eCommerce components allows institutional and individual subscribers access to the entire site as well as providing users the option of purchasing individual chapters.
“We are very honored to be associated in supporting the OMMBID platform,” said Impelsys CEO Sameer Shariff. “As the leading source for genetics information, we look forward to implementing the latest web technologies in order to provide OMMBID users the best experience in getting to their content.”
About Impelsys
Impelsys, a leader in providing electronic content delivery solutions to the global publishing market operates two groups —Impelsys Products and Impelsys Services — that help clients compete, evolve and grow in an increasingly complex marketplace. Impelsys products include iPlatform™, VirtualPages™ and SmartCD™. These products help publishers deliver content online quickly and cost effectively. Impelsys services through its offshore delivery center, helps its customers with software development, maintenance, multimedia development and eLearning services.
Impelsys’ passion for client success has helped it build long term partnerships with its customers becoming critical in the client’s electronic delivery strategy. Leading clients, including McGraw-Hill, Reed Elsevier, Wolters Kluwer, Thomson, Springer, Benchmark Education, Marshall Cavendish and Houghton Mifflin rely on the company’s unique approach to drive growth and market momentum. Headquartered in New York City, Impelsys operates across North America, Europe and India. For more information, please visit www.impelsys.com.
###
Contact
Impelsys
Sherri Pfefer
9546513505
impelsys.com
Sherri Pfefer
9546513505
impelsys.com
Contact
Categories